MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Danaher Corporation ROA Ratio 2011-2026 | DHR
Annual ROA Ratio Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.33 | 5.03 | 5.64 | 8.55 | 7.73 | 4.79 | 4.85 | 5.54 | 5.34 | 5.64 | 6.96 | 7.02 | 7.77 | 7.26 | 7.25 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.55 | 4.33 | 6.25 |
Quarterly ROA Ratio Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.21 | 2.05 | 4.11 | 6.18 | 5.53 | 6.93 | 7.16 | 5.74 | 6.9 | 6.65 | 5.58 | 3.16 | 5.18 | 5.1 | 5.06 | 4.81 | 4.35 | 4.66 | 4.9 | 5.54 | 5.82 | 5.66 | 5.44 | 5.34 | 5.16 | 4.79 | 5.05 | 5.64 | 5.42 | 7.46 | 7.46 | 6.96 | 7.32 | 6.25 | 6.64 | 7.02 | 7.51 | 7.39 | 7.34 | 7.77 | 7.41 | 7.35 | 7.4 | 7.26 | 7.25 | 7.34 | 7.68 | 7.25 | 1.75 | 2.17 | 1.43 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.77 | 1.21 | 5.74 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
3.33 | $ 9.25 | -0.11 % | $ 616 M |  USA |
|
Biodesix
BDSX
|
-44.15 | $ 14.56 | -0.27 % | $ 1.89 B | USA |
 |
DarioHealth Corp.
DRIO
|
-37.9 | $ 8.45 | - | $ 33.7 M |  Israel |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | Israel |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
IDEXX Laboratories
IDXX
|
31.62 | $ 566.57 | -1.17 % | $ 45.6 B | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 462.67 | -0.84 % | $ 13.3 B | USA |
 |
Illumina
ILMN
|
-19.4 | $ 121.35 | -2.45 % | $ 19.3 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.78 | $ 0.62 | 1.06 % | $ 61.9 M |  Irlanda |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
OPKO Health
OPK
|
0.64 | $ 1.14 | -2.44 % | $ 791 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
8.6 | $ 16.93 | -2.48 % | $ 379 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
VolitionRx Limited
VNRX
|
-289.99 | $ 0.19 | -3.63 % | $ 18.3 M |  Singapore |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 160.77 | -2.64 % | $ 7.97 B | USA |
 |
Organovo Holdings
ONVO
|
-16.98 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
121.6 | - | -16.95 % | $ 1.54 M | USA |
 |
Waters Corporation
WAT
|
12.66 | $ 295.27 | -1.76 % | $ 17.6 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-258.47 | $ 4.79 | 6.32 % | $ 2.57 M | USA |
 |
PerkinElmer
PKI
|
1.98 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |
 |
Exagen
XGN
|
-34.39 | $ 2.71 | -2.87 % | $ 58.4 M | USA |
 |
Interpace Biosciences
IDXG
|
45.31 | $ 1.73 | 2.37 % | $ 7.59 M | USA |
 |
Soleno Therapeutics
SLNO
|
3.71 | $ 31.12 | -2.23 % | $ 1.58 B | USA |
 |
RadNet
RDNT
|
-0.5 | $ 57.9 | -2.54 % | $ 4.35 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B |  Niderland |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 482.91 | -1.22 % | $ 182 B | USA |
 |
Celcuity
CELC
|
-37.95 | $ 114.04 | -0.67 % | $ 5.33 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Senseonics Holdings
SENS
|
-54.73 | $ 6.53 | -0.53 % | $ 272 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 265.93 | -0.91 % | $ 22.1 B | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 7.58 | -2.32 % | $ 971 M | USA |
 |
Psychemedics Corporation
PMD
|
-33.7 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-32.34 | $ 26.54 | -2.43 % | $ 34.4 M | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 17.22 | -1.43 % | $ 918 M | USA |